BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31373158)

  • 21. Acquired Downregulation of Donor-Specific Antibody Production After ABO-Incompatible Kidney Transplantation.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Aoki T; Kamimura M; Narita I; Tomita Y; Takahashi K
    Am J Transplant; 2017 Jan; 17(1):115-128. PubMed ID: 27343838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients.
    Schlößer HA; Thelen M; Dieplinger G; von Bergwelt-Baildon A; Garcia-Marquez M; Reuter S; Shimabukuro-Vornhagen A; Wennhold K; Haustein N; Buchner D; Heiermann N; Kleinert R; Wahba R; Ditt V; Kurschat C; Cingöz T; Becker J; Stippel DL; von Bergwelt-Baildon M
    Am J Transplant; 2017 Feb; 17(2):542-550. PubMed ID: 27529836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.
    Masterson R; Hughes P; Walker RG; Hogan C; Haeusler M; Robertson AR; Millar R; Suh N; Cohney SJ
    Am J Transplant; 2014 Dec; 14(12):2807-13. PubMed ID: 25389083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes.
    Adam BA; Smith RN; Rosales IA; Matsunami M; Afzali B; Oura T; Cosimi AB; Kawai T; Colvin RB; Mengel M
    Am J Transplant; 2017 Nov; 17(11):2841-2850. PubMed ID: 28444814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO-incompatible living kidney transplantation.
    Cen M; Wang R; Kong W; Deng H; Lei W; Chen J
    Clin Transplant; 2020 Sep; 34(9):e14050. PubMed ID: 32713064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
    Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
    Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.
    Jänigen BM; Salabè C; Glatz T; Thomusch O; Lässle C; Fichtner-Feigl S; Zschiedrich S; Pisarski P
    Langenbecks Arch Surg; 2019 Dec; 404(8):999-1007. PubMed ID: 31456076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
    PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a Hyperacute Rejection Model of ABO-Incompatible Renal Transplantation in Nonhuman Primates.
    Wang J; Feng H; Zhang C; Zhong S; Wang L; Zhu L; Chen S; Chen G
    Front Immunol; 2021; 12():807604. PubMed ID: 34970278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for postoperative bleeding in ABO-incompatible kidney transplantation.
    Kim MH; Jun KW; Hwang JK; Kim JI; Chung BH; Choi BS; Kim YS; Yang CW; Moon IS
    Clin Transplant; 2015 Apr; 29(4):365-72. PubMed ID: 25646784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABO incompatible kidney transplantation: the Saudi experience.
    Ali T; Broering D; Aleid H; Brockmann J; Alhumaidan H; Hammad E; Shah Y; Elgamal H; Alahmadi I; Hussein M; Raza S; Alabassi A; Ibrahim I; Shoukri M; Almeshari K
    Saudi J Kidney Dis Transpl; 2019; 30(3):655-662. PubMed ID: 31249230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: A single-center retrospective cohort study.
    Okada M; Narumi S; Hasegawa Y; Futamura K; Hiramitsu T; Ichimori T; Goto N; Kobayashi T; Uchida K; Takeda A; Watarai Y
    Clin Transplant; 2023 Feb; 37(2):e14915. PubMed ID: 36634703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
    Hirzel C; Projer L; Atkinson A; Surial B; Mueller NJ; Manuel O; Mombelli M; van Delden C; Hirsch HH; Boggian K; Walti LN; Sidler D; Hadaya K; Dickenmann M; Müller TF; Binet I; Golshayan D; Huynh-Do U;
    Transplantation; 2022 Sep; 106(9):1875-1883. PubMed ID: 35389968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.